openPR Logo
Press release

Scientifically Proven Treatment for Alzheimer's Disease and Dementia Now Available Across the USA and Canada

07-15-2024 10:56 PM CET | Health & Medicine

Press release from: ABNewswire

Scientifically Proven Treatment for Alzheimer's Disease

forBetterMinds is thrilled to announce that its revolutionary, evidence-based treatment for Alzheimer's and dementia is now accessible to individuals across the USA and Canada. This innovative therapy, successfully trialed for over 20 years in the United Kingdom (UK), is designed to enhance memory, understanding of conversation, word-finding ability, awareness of time and place, and the ability to follow instructions.

The forBetterMinds program utilizes cognitive stimulation therapy (CST), delivered through interactive, virtual one-on-one sessions. These sessions are conducted via Zoom by certified forBetterMinds CST Coaches and consist of 14 one-hour interactive sessions over seven weeks. This structured yet flexible approach provides comprehensive dementia care in the comfort of one's home.

Cognitive Stimulation therapy has been rigorously tested and proven to deliver significant benefits, making it a trusted method in the UK for decades. Now, it is available to people in the USA and Canada who are living with mild cognitive impairment (MCI), as well as early to mid-stage Alzheimer's Disease, Lewy Body dementia, and vascular dementia.

In light of the limited effectiveness of drug treatments for dementia, researchers have developed cognitive stimulation therapy to slow the progression of dementia and alleviate its symptoms. CST offers a non-pharmacological alternative that has shown remarkable results in enhancing the mental functions of individuals. It is an essential tool for those seeking to improve their quality of life and maintain independence for as long as possible.

People living with dementia and mild cognitive impairment in any town or city across the USA and Canada can now access the benefits of CST through forBetterMinds' telehealth delivery. The virtual format eliminates geographical barriers, ensuring that high-quality care is available to everyone, regardless of location.

The benefits of CST are manifold, including:

*
Enhanced memory

*
Improved understanding of conversations

*
Better word-finding ability

*
Increased awareness of time and place

*
Enhanced ability to follow instructions

These improvements contribute significantly to the quality of life for individuals with dementia and their caregivers, allowing them to stay in their homes longer and enjoy more fulfilling lives.

forBetterMinds is dedicated to improving the lives of people with dementia and their caregivers. By offering this scientifically proven, evidence-based therapy, the company aims to slow the progress of dementia, increase the quality of life for individuals, and provide essential support for caregivers.

About forBetterMinds

forBetterMinds, a leader in cognitive health, has been at the forefront of dementia care innovation. Their mission is to provide accessible, effective treatments that enhance the lives of those affected by dementia and cognitive impairments. With a strong foundation in the UK, forBetterMinds is proud to serve the USA and Canada, bringing world-class care to your doorstep.

To learn more about forBetterMinds and the benefits of Cognitive Stimulation Therapy, visit forbetterminds.com [https://forbetterminds.com/] and follow them on Facebook [https://www.facebook.com/forbetterminds]and Instagram [https://www.instagram.com/forbetterminds/].

Location: https://www.google.com/maps/embed?pb=!1m14!1m8!1m3!1d11538.264586211555!2d-79.3973321!3d43.6987823!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x882b33b3c852b97d%3A0xc7686fdf2518bd19!2sforBetterMinds!5e0!3m2!1sen!2s!4v1721069297104!5m2!1sen!2s

Media Contact
Company Name: forBetterMinds
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=scientifically-proven-treatment-for-alzheimers-disease-and-dementia-now-available-across-the-usa-and-canada]
Address:1920 Yonge St Suite 200
City: Toronto
State: ON M4S 3E2
Country: Canada
Website: https://forbetterminds.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Scientifically Proven Treatment for Alzheimer's Disease and Dementia Now Available Across the USA and Canada here

News-ID: 3582184 • Views:

More Releases from ABNewswire

RC Adventures, LLC Opens Community-Focused Hobby Shop with Indoor Rock Crawling Course and Rental Equipment
RC Adventures, LLC Opens Community-Focused Hobby Shop with Indoor Rock Crawling …
RC Adventures, LLC has opened its doors as a comprehensive remote control hobby destination featuring both brick-and-mortar and online shopping experiences. The new store distinguishes itself with an indoor rock crawling course, dedicated kids' sandbox, construction equipment dirt area, and rental services, creating a community hub for RC enthusiasts of all ages and skill levels. RC Adventures, LLC has officially launched operations as a full-service remote control hobby destination, combining traditional
Caneca Coffee Roasters Launches with Experiential Approach to Specialty Coffee, Transforming Morning Ritual into Journey
Caneca Coffee Roasters Launches with Experiential Approach to Specialty Coffee, …
Caneca Coffee Roasters has entered the specialty coffee market with a distinctive philosophy that positions every bean as a story and every cup as a transformative journey. The new roastery offers carefully crafted blends including Shanta's Fruit, Golden Dawn Blend, Espresso Blend, House Blend, and a bold DECAF option, each designed to capture vibrant flavors from the world's finest coffee-growing regions. Caneca Coffee Roasters has officially launched operations with an experiential
Atlanta's Trio Tailoring, LLC Celebrates Over a Decade of Making Custom Clothing Accessible to All Professionals
Atlanta's Trio Tailoring, LLC Celebrates Over a Decade of Making Custom Clothing …
Trio Tailoring, LLC marks more than ten years of serving Atlanta's professional community with affordable, high-quality custom clothing. The established clothier has become the go-to destination for wedding grooms, attorneys, and corporate professionals seeking personalized garments that deliver exceptional value without compromising on craftsmanship or style. Since establishing its presence in Atlanta's fashion and professional apparel market over a decade ago, Trio Tailoring, LLC has built a loyal following among discerning
Dr. Chris Chlebowski Introduces Axobotanica, a New Product and Education Brand Built on Two Decades of Expertise
Dr. Chris Chlebowski Introduces Axobotanica, a New Product and Education Brand B …
Internationally recognized educator and speaker Dr. Chris Chlebowski is bringing his two decades of professional experience to consumers through Axobotanica-a family-owned retail and education brand offering thoughtfully crafted products and clear, trustworthy information. The company reflects a commitment to quality, transparency, and meaningful customer experiences. Axobotanica LLC launches as a new product and education brand shaped by nearly twenty years of professional experience. Co-founded by Dr. Chris Chlebowski, the platform blends

All 5 Releases


More Releases for Alzheimer

Alzheimer Therapeutics Market Breakthrough Innovations and Increasing Treatment …
The Alzheimer Therapeutics Market is rapidly evolving as disease-modifying therapies, early-stage diagnostic tools, and biomarker-driven treatment approaches reshape global management of Alzheimer's disease (AD). As one of the most prevalent neurodegenerative conditions, Alzheimer's affects millions of older adults worldwide. With recent regulatory approvals of anti-amyloid monoclonal antibodies, enhanced imaging technology, and increased R&D investment, the market is experiencing unprecedented momentum. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/51928 Key Takeaways • Disease-modifying
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion. Data Bridge
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,